-+ 0.00%
-+ 0.00%
-+ 0.00%

BLACK DIAMOND THERAPEUTICS ANNOUNCES POSITIVE UPDATED SILEVERTINIB PHASE 2 RESULTS, FDA FEEDBACK SUPPORTING A CLEAR PATH TO POTENTIAL REGISTRATION IN 1L EGFR-NCM NSCLC, AND PROVIDES CORPORATE UPDATE

Reuters·11/10/2026 11:32:53